News

Researchers propose antiviral treatment options for MERS-CoV


 

Dr. Falzarano and his colleagues are part of a team that includes Dr. Vincent Munster, chief of the Virus Ecology Unit in NIAID’s Laboratory of Virology, who is leading the NIAID Rocky Mountain Laboratories team investigating the ecology and molecular biology of the new coronavirus.

The NIAID researchers and the authors of these reports disclosed no relevant conflicts.

mlesney@frontlinemedcom.com

Pages

Recommended Reading

Four different PCV13 schedules yield similar antibody levels
MDedge Internal Medicine
Novel breath test helped identify invasive aspergillosis
MDedge Internal Medicine
Hospital Clostridium difficile cases nearly doubled during 2000s
MDedge Internal Medicine
Low, high dose vancomycin equally effective in C. difficile
MDedge Internal Medicine
High-dose intravaginal metronidazole/miconazole may help BV
MDedge Internal Medicine
Single-dose oritavancin shows efficacy against skin infections
MDedge Internal Medicine
No inverse link found between H. pylori and gastroesophageal reflux disease
MDedge Internal Medicine
Dalbavancin stands up to severe skin infections
MDedge Internal Medicine
Stats show MRSA declining, especially in hospitals
MDedge Internal Medicine
Antibiotic-related illness in U.S. tops 2 million annually
MDedge Internal Medicine